In this study, we sought to combine three tumor markers, CK20, EpCAM, and Pan-CK, through triple-parameter FCM (tFCM), with the aim of evaluating whether tFCM could enhance the precision and efficiency of LN metastasis detection in CRC patients. This evidence concerns the gene KRT20 and neoplasm.